Biologics Market is projected to reach USD 412 billion in 2024, with a CAGR of 8.25%

Market Insights

As per recent research by MarkNtel Advisors, The Global Biologics Market size is valued at USD 412 billion in 2024 and is projected to grow at a CAGR of around 8.25% during the forecast period, i.e., 2024-30.

Global Biologics Market Driver:

Increasing Inclination Towards Gene Therapy & Cellular Therapy to Boost the Market Growth – Due to their ability to repair or substitute damaged tissues, gene and cellular treatments have experienced considerable growth in adoption over the historical years. Moreover, the rising investments in research & development of cell and gene therapies have been further bolstering their adoption, owing to the improved efficacy of new drugs. Additionally, there has been increased funding and investments for R&D purposes of cell and gene therapies by companies like Ori Biotech, AstraZeneca Plc, GlaxoSmithKline Biologicals, etc., for the launch of innovative products.

Thus, with enhanced investment, the process of pre-commercialization and market launch has been accelerated, which has been contributing to the market growth. Also, over the historical years, the approvals of these medicines have been accelerated by government organizations like the United States Food and Drug Administration (FDA), the European Medicines Agency (EMA), etc. Consequently, as approvals for cell and gene therapies would accelerate in the coming years, it would create an opportunity for their enhanced adoption in the coming years as well.

Request Free Sample Report: https://www.marknteladvisors.com/query/request-sample/global-biologics-market.html

Market Segmentation and Consumer Behavior:

By Therapeutic Application

Oncology- Market Size & Forecast 2019-2030, (USD Million)
Infectious Disease- Market Size & Forecast 2019-2030, (USD Million)
Autoimmune Disease- Market Size & Forecast 2019-2030, (USD Million)
Diabetes- Market Size & Forecast 2019-2030, (USD Million)
Cardiovascular Diseases- Market Size & Forecast 2019-2030, (USD Million)
Others (Inflammatory Bowel Diseases, Respiratory Disorders, Ophthalmic Disorders, etc.)- Market Size & Forecast 2019-2030, (USD Million)

By Drug Class

Recombinant Proteins- Market Size & Forecast 2019-2030, (USD Million)
- Hormones- Market Size & Forecast 2019-2030, (USD Million)
- Cytokines- Market Size & Forecast 2019-2030, (USD Million)
Monoclonal Antibodies- Market Size & Forecast 2019-2030, (USD Million)
Blood & Blood Components- Market Size & Forecast 2019-2030, (USD Million)
Cellular & Gene Therapy- Market Size & Forecast 2019-2030, (USD Million)
Vaccines- Market Size & Forecast 2019-2030, (USD Million)
Others- Market Size & Forecast 2019-2030, (USD Million)

By Source

Microbes- Market Size & Forecast 2019-2030, (USD Million)
Humans- Market Size & Forecast 2019-2030, (USD Million)
Others (Rodents, Plants, etc.)- Market Size & Forecast 2019-2030, (USD Million)

Read Full Report: https://www.marknteladvisors.com/research-library/global-biologics-market.html

Biologics Market Geographical Analysis:

By Region:

North America
South America
Europe
The Middle East & Africa
Asia-Pacific

Key Players and Competitive Strategies in the Biologics Market

Several prominent players dominate the Biologics Market, including:

Bristol-Myers Squibb
Pfizer
Sanofi
Janssen Biotech, Inc.
Bayer AG
Merck & Co.
Amgen Inc.
Abbott GmbH
Novartis
AstraZeneca Plc
GlaxoSmithKline Biologicals
Moderna, Inc.
Ferring Pharmaceuticals Inc.
Aimmune Therapeutics, Inc.
Hoffman La Roche

Report Delivery - MarkNtel Advisors offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.

Questions Addressed in this Study

1.What factors are driving the Biologics Market growth?

2.How is the Biologics Market expected to grow over the next five years?

3.What are the key insights into the current trends in the Biologics Market?

4.What is the current size of the Biologics Market, and how is it projected to change in the future?

5.What is the future outlook for the Biologics Market in terms of technological advancements and market expansion?

Request Customization - https://www.marknteladvisors.com/query/request-customization/global-biologics-market.html

Why MarkNtel Advisors?

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals.